PhillipCapital Securities reports stake in BrightPath Biotherapeutics exceeded 5% [Large Shareholding Report]

The story

A substantial shareholding report concerning BrightPath Biotherapeutics disclosed that PhillipCapital Securities’ shareholding had exceeded 5%.

This information indicates that the shareholding of a specific shareholder was disclosed in accordance with statutory disclosure requirements.

At a glance

EntityPhillipCapital Securities reports a stake exceeding 5%

Target audienceShares of BrightPath Biotherapeutics are covered

ProcedureDisclosure in a Large Shareholding Report

Reference information. Every claim resolves to something the story actually named.

We read each source in full and checked they agree on the core claim.

1/ 1 agree

All of them report the same thing.

KabutanNews

AgreesOpen

Reference information generated from public sources. It does not solicit or advise on investments. Prices are 15-minute delayed.